SEC Form 4 · accession 0000899243-17-018102
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
APPLE TREE PARTNERS II LP
10% Owner
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 8:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Jul 5, 2017 | C | 18,771 | — | A | 19,022 | D | |
| Common StockF2,F3 | Jul 5, 2017 | C | 1,780,564 | — | A | 1,799,586 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF3,F1 | — | Jul 5, 2017 | C | 1,250,000 | D | — | — | Common Stock | 12,579 | 0 | D |
| Series A-1 Preferred StockF3,F1 | — | Jul 5, 2017 | C | 615,384 | D | — | — | Common Stock | 6,192 | 0 | D |
| Series B Preferred StockF3,F2 | — | Jul 5, 2017 | C | 3,706,056 | D | — | — | Common Stock | 372,955 | 0 | D |
| Series C-1 Preferred StockF3,F2 | — | Jul 5, 2017 | C | 2,967,025 | D | — | — | Common Stock | 298,583 | 0 | D |
| Series C-2 Preferred StockF3,F2 | — | Jul 5, 2017 | C | 4,238,607 | D | — | — | Common Stock | 426,547 | 0 | D |
| Series D Preferred StockF3,F2 | — | Jul 5, 2017 | C | 6,781,770 | D | — | — | Common Stock | 682,476 | 0 | D |
Explanation of responses
- F1The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date.
- F2The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- F3Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P.